Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2003;41:230-236
Published online before print January 20, 2003, doi: 10.1161/01.HYP.0000052542.68896.2B
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
41/2/230    most recent
01.HYP.0000052542.68896.2Bv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kozàkovà, M.
Right arrow Articles by Salvetti, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kozàkovà, M.
Right arrow Articles by Salvetti, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Remodeling
Right arrow Hypertrophy
Right arrow Clinical Studies
Right arrow Echocardiography

(Hypertension. 2003;41:230.)
© 2003 American Heart Association, Inc.


Scientific Contributions

Myocardial Ultrasonic Backscatter in Hypertension

Relation to Aldosterone and Endothelin

Michaela Kozàkovà; Simona Buralli; Carlo Palombo; Giampaolo Bernini; Angelica Moretti; Stefania Favilla; Stefano Taddei; Antonio Salvetti

From the Department of Internal Medicine, University of Pisa (M.K., S.B., C.P., G.B., A.M., S.F., S.T., A.S.), and the Institute of Clinical Physiology (C.P.), National Research Council (CNR), Pisa, Italy.

Correspondence to Carlo Palombo, MD, FESC, CNR, Institute of Clinical Physiology, Via Trieste 41, 56126 Pisa, Italy. E-mail palombo{at}ifc.cnr.it

A disproportionate accumulation of fibrillar collagen is a characteristic feature of hypertensive heart disease, but the extent of myocardial fibrosis may differ in different models of hypertension. In experimental studies, aldosterone and endothelins emerge as important determinants of myocardial fibrosis. Changes in myocardial extracellular matrix and collagen deposition can be estimated noninvasively by analysis of the ultrasonic backscatter signal, which arises from tissue heterogeneity within the myocardium and describes myocardial texture. This study was designed to investigate the relations between myocardial integrated backscatter and circulating aldosterone and immunoreactive endothelin in human hypertension. The study population consisted of 56 subjects: 14 healthy normotensive volunteers and 42 hypertensive patients (14 with primary aldosteronism, 7 with renovascular hypertension, and 21 with essential hypertension). The patients with essential and secondary hypertension were matched for age, gender, body mass index, and blood pressure. Myocardial integrated backscatter at diastole was 19.8±2.0 and 20.8±2.9 decibels in normotensive control subjects and patients with essential hypertension and significantly higher in patients with primary aldosteronism (27.4±3.8 decibels, P<0.01) and renovascular hypertension (26.8±4.8 decibels, P<0.01). In the population as a whole, as well as in the hypertensive subpopulation, myocardial integrated backscatter was directly related to plasma aldosterone (r=0.73 and 0.71, P<0.01 for both) and immunoreactive endothelin (r=0.60 and 0.56, P<0.01 for both). The data of this study suggest that in human hypertension, circulating aldosterone and immunoreactive endothelin may induce alterations in left ventricular myocardial texture, possibly related to increased myocardial collagen content.


Key Words: hypertension, arterial • hypertrophy • fibrosis • aldosterone • endothelin • echocardiography




This article has been cited by other articles:


Home page
Ther Adv Cardiovasc DisHome page
E. Agabiti-Rosei, M. L. Muiesan, and M. Salvetti
Review: New approaches to the assessment of left ventricular hypertrophy
Therapeutic Advances in Cardiovascular Disease, December 1, 2007; 1(2): 119 - 128.
[Abstract] [PDF]


Home page
CirculationHome page
E. O. Lillie, M. Mahata, S. Khandrika, F. Rao, R. A. Bundey, G. Wen, Y. Chen, L. Taupenot, D. W. Smith, S. K. Mahata, et al.
Heredity of Endothelin Secretion: Human Twin Studies Reveal the Influence of Polymorphism at the Chromogranin A Locus, a Novel Determinant of Endothelial Function
Circulation, May 1, 2007; 115(17): 2282 - 2291.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
N. Daunt
Adrenal Vein Sampling: How to Make It Quick, Easy, and Successful
RadioGraphics, October 1, 2005; 25(suppl_1): S143 - S158.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Stowasser, J. Sharman, R. Leano, R. D. Gordon, G. Ward, D. Cowley, and T. H. Marwick
Evidence for Abnormal Left Ventricular Structure and Function in Normotensive Individuals with Familial Hyperaldosteronism Type I
J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5070 - 5076.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Milliez, X. Girerd, P.-F. Plouin, J. Blacher, M. E. Safar, and J.-J. Mourad
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
J. Am. Coll. Cardiol., April 19, 2005; 45(8): 1243 - 1248.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Kozakova, E. Ferrannini, and C. Palombo
Relation Between Left Ventricular Midwall Function and Coronary Vasodilator Capacity in Arterial Hypertension
Hypertension, October 1, 2003; 42(4): 528 - 533.
[Abstract] [Full Text] [PDF]